Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature.

scientific article

Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PARKRELDIS.2013.01.007
P932PMC publication ID3653978
P698PubMed publication ID23473718
P5875ResearchGate publication ID235894296

P50authorRobert ChenQ38640918
Benzi M KlugerQ64856652
P2093author name stringMatthew Vonloh
P2860cites workInduction of visual extinction by rapid-rate transcranial magnetic stimulation of parietal lobeQ48162339
Reciprocal facilitation of motor evoked potentials immediately before voluntary movements in Parkinson's disease.Q48170601
Disturbed intracortical excitability in early Parkinson's disease is l-DOPA dose related: a prospective 12-month paired TMS studyQ48193843
Improvement in Parkinsonian symptoms after repetitive transcranial magnetic stimulationQ48237165
The effect of cortical repetitive transcranial magnetic stimulation on cognitive event-related potentials recorded in the subthalamic nucleusQ48243098
Pallidotomy does not ameliorate abnormal intracortical inhibition in Parkinson's diseaseQ48252920
Cognitive event-related potentials and oscillations in the subthalamic nucleusQ48286285
Subthalamic nucleus stimulation modulates afferent inhibition in Parkinson disease.Q48294228
Safety of transcranial magnetic stimulation in patients with implanted deep brain stimulatorsQ48300060
Low-frequency repetitive transcranial magnetic stimulation and off-phase motor symptoms in Parkinson's diseaseQ48308865
Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's diseaseQ48315117
Effects of successive repetitive transcranial magnetic stimulation on motor performances and brain perfusion in idiopathic Parkinson's diseaseQ48341141
0.2-Hz repetitive transcranial magnetic stimulation has no add-on effects as compared to a realistic sham stimulation in Parkinson's diseaseQ48347022
Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson's diseaseQ48373821
Paired transcranial magnetic stimulation for the early diagnosis of corticobasal degeneration.Q48398238
Beneficial effect of transcranial magnetic stimulation on sleep in Parkinson's diseaseQ48409231
The silent period of the thenar muscles to contralateral and ipsilateral deep brain stimulationQ48410588
Limb-kinetic apraxia in corticobasal degeneration: clinical and kinematic featuresQ48412500
Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's diseaseQ48455407
Corticomotor facilitation associated with observation and imagery of hand actions is impaired in Parkinson's diseaseQ81416478
Observations on the cortical silent period in Parkinson's diseaseQ81552222
Effects of repetitive transcranial magnetic stimulation on voice and speech in Parkinson's diseaseQ82258807
Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutationsQ82664675
Impairment of motor cortex plasticity in Parkinson's disease, as revealed by theta-burst-transcranial magnetic stimulation and transcranial random noise stimulationQ83400479
Congenital mirror movements in Parkinson's disease: clinical and neurophysiological observationsQ84397741
Controlled trial on the effect of 10 days low-frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's diseaseQ22252877
A noninvasive imaging approach to understanding speech changes following deep brain stimulation in Parkinson's diseaseQ24654136
Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996Q28262619
Stimulation over the human supplementary motor area interferes with the organization of future elements in complex motor sequencesQ29394519
Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson diseaseQ30470467
What have We Learned from "Perturbing" the Human Cortical Motor System with Transcranial Magnetic Stimulation?Q30478753
Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease.Q30495446
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's diseaseQ33567182
Transcranial magnetic stimulation in movement disorders.Q33790509
Repetitive transcranial magnetic stimulation has a beneficial effect on bradykinesia in Parkinson's diseaseQ33859131
Corticostriatal functional interactions in Parkinson's disease: a rTMS/[11C]raclopride PET studyQ34258327
The effect of exercise training in improving motor performance and corticomotor excitability in people with early Parkinson's diseaseQ34340821
Distinguishing SWEDDs patients with asymmetric resting tremor from Parkinson's disease: a clinical and electrophysiological studyQ34376763
Slow (1 Hz) repetitive transcranial magnetic stimulation (rTMS) induces a sustained change in cortical excitability in patients with Parkinson's disease.Q34383595
Altered plasticity of the human motor cortex in Parkinson's disease.Q34461666
Transcranial magnetic stimulation in neurologyQ34535244
Transcranial magnetic stimulation: neurophysiological applications and safetyQ35024888
Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literatureQ35485286
Motor cortex dysfunction revealed by cortical excitability studies in Parkinson's disease: influence of antiparkinsonian treatment and cortical stimulationQ36015136
The plastic human brain cortexQ36196554
An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's diseaseQ36237800
Safety of rTMS to non-motor cortical areas in healthy participants and patientsQ36357638
Characteristics of the sequence effect in Parkinson's diseaseQ36663013
Safety and tolerability of repetitive transcranial magnetic stimulation in patients with epilepsy: a review of the literatureQ36817712
Transcranial magnetic stimulation as a method for investigating the plasticity of the brain in Parkinson's disease and dystoniaQ37082112
Safety study of 50 Hz repetitive transcranial magnetic stimulation in patients with Parkinson's disease.Q37155828
Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humansQ37224405
The supplementary motor area contributes to the timing of the anticipatory postural adjustment during step initiation in participants with and without Parkinson's diseaseQ37387707
Transcranial magnetic simulation in the treatment of migraineQ37739594
Effects of inhibitory rTMS on bladder function in Parkinson's disease patientsQ46169449
Spike-timing-related plasticity is preserved in Parkinson's disease and is enhanced by dopamine: evidence from transcranial magnetic stimulationQ46295695
Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's diseaseQ46296599
Effects of posture-related changes in motor cortical output on central oscillatory activity of pathological origin in humansQ46310213
Motor cortical physiology in patients and asymptomatic carriers of parkin gene mutationsQ46401793
Subthalamic nucleus stimulation restores corticospinal facilitation in Parkinson's diseaseQ46401830
Effect of repetitive TMS and fluoxetine on cognitive function in patients with Parkinson's disease and concurrent depressionQ46491803
Dopaminergic drugs restore facilitatory premotor-motor interactions in Parkinson diseaseQ46546789
Motor learning of hands with auditory cue in patients with Parkinson's diseaseQ46549750
rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson diseaseQ46664052
Changes in processing of proprioceptive information in Parkinson's disease and multiple system atrophyQ46727224
Therapeutic effect of repetitive transcranial magnetic stimulation in Parkinson's disease: analysis of [11C] raclopride PET studyQ46902462
Cortical inhibition in Parkinson's disease: new insights from early, untreated patientsQ46928235
Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.Q46943000
Motor control in mirror movements: studies with transcranial magnetic stimulationQ48115155
Lack of post-exercise depression of corticospinal excitability in patients with Parkinson's diseaseQ48125048
Akinesia in Parkinson's disease. II. Effects of subthreshold repetitive transcranial motor cortex stimulationQ48125737
Akinesia in Parkinson's disease. I. Shortening of simple reaction time with focal, single-pulse transcranial magnetic stimulationQ48125750
Limb contractures in levodopa-responsive parkinsonism: a clinical and investigational study of seven new cases.Q48128765
Dopamine levels after repetitive transcranial magnetic stimulation of motor cortex in patients with Parkinson's disease: preliminary resultsQ48132910
Motor cortical inhibition and the dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonismQ48142740
Repetitive transcranial stimulation for freezing of gait in Parkinson's diseaseQ48160786
Transcranial magnetic stimulation for migraine: a safety reviewQ37765637
Modulation of cortical excitability induced by repetitive transcranial magnetic stimulation: Influence of timing and geometrical parameters and underlying mechanismsQ37807755
The emerging use of technology for the treatment of depression and other neuropsychiatric disordersQ37841154
Differential effect of linguistic and non-linguistic pen-holding tasks on motor cortex excitability.Q38387824
Apomorphine can increase cutaneous inhibition of motor activity in Parkinson's diseaseQ39421438
Abnormal somatotopic arrangement of sensorimotor interactions in dystonic patientsQ39635574
Abnormal sensorimotor integration is related to disease severity in Parkinson's disease: a TMS studyQ39670028
Sensorimotor integration is abnormal in asymptomatic Parkin mutation carriers: a TMS studyQ39822345
Double-blind, randomized, placebo controlled trial on the effect of 10 days low-frequency rTMS over the vertex on sleep in Parkinson's disease.Q39851769
Training effects outweigh effects of single-session conventional rTMS and theta burst stimulation in PD patientsQ40030977
Dorsolateral prefrontal cortex: a possible target for modulating dyskinesias in Parkinson's disease by repetitive transcranial magnetic stimulationQ41935713
The nature and time course of cortical activation following subthalamic stimulation in Parkinson's diseaseQ42464599
Involvement of the cerebellothalamocortical pathway in Parkinson diseaseQ42769496
Lack of LTP-like plasticity in primary motor cortex in Parkinson's disease.Q42781596
Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation Combined with Physical Therapy on l-Dopa-Induced Painful Off-Period Dystonia in Parkinson's DiseaseQ42847965
A motor cortex excitability and gait analysis on Parkinsonian patientsQ42868741
Excitability of the lower-limb area of the motor cortex in Parkinson's diseaseQ42950583
Premovement facilitation of corticospinal excitability in patients with Parkinson's diseaseQ43144133
Dopamine influences primary motor cortex plasticity and dorsal premotor-to-motor connectivity in Parkinson's disease.Q43201860
1 Hz rTMS preconditioned by tDCS over the primary motor cortex in Parkinson's disease: effects on bradykinesia of arm and handQ43208597
Effects of motor imagery on motor cortical output topography in Parkinson's diseaseQ43668450
Impaired motor cortical inhibition in Parkinson's disease: motor unit responses to transcranial magnetic stimulationQ43683253
Short-term effects of repetitive transcranial magnetic stimulation on speech and voice in individuals with Parkinson's diseaseQ43743524
Effect of apomorphine on cortical inhibition in Parkinson's disease patients: a transcranial magnetic stimulation studyQ43783853
Therapeutic effect and mechanism of repetitive transcranial magnetic stimulation in Parkinson's diseaseQ43791530
Deep brain stimulation of both subthalamic nucleus and internal globus pallidus restores intracortical inhibition in Parkinson's disease paralleling apomorphine effects: a paired magnetic stimulation study.Q43860548
Repetitive paired-pulse transcranial magnetic stimulation affects corticospinal excitability and finger tapping in Parkinson's diseaseQ44016781
Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's diseaseQ44023102
Abnormal conditioning effect of transcranial magnetic stimulation on soleus H-reflex during voluntary movement in Parkinson's diseaseQ44078467
Theta burst stimulation over the primary motor cortex does not induce cortical plasticity in Parkinson's diseaseQ44082268
Altered sensorimotor integration in Parkinson's diseaseQ44106004
Effects of subthalamic nucleus (STN) stimulation on motor cortex excitabilityQ44131395
Direct demonstration of long latency cortico-cortical inhibition in normal subjects and in a patient with vascular parkinsonism.Q44205417
Cortico-motor excitability of the lower limb motor representation: a comparative study in Parkinson's disease and healthy controlsQ44237429
Silent period measurement revives as a valuable diagnostic tool with transcranial magnetic stimulationQ44413229
Short and long latency afferent inhibition in Parkinson's diseaseQ44477078
Intracortical inhibition and facilitation are impaired in patients with early Parkinson's disease: a paired TMS study.Q44489205
Increased cortical excitability with longer duration of Parkinson's disease as evaluated by transcranial magnetic stimulationQ44514761
Motor cortex inhibition induced by acoustic stimulation.Q44801588
Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson's disease.Q45049276
Abnormal excitability of premotor-motor connections in de novo Parkinson's diseaseQ45127827
Theta burst stimulation of the human motor cortexQ45233486
Cholinergic cortical circuits in Parkinson's disease and in progressive supranuclear palsy: a transcranial magnetic stimulation studyQ45309562
Cerebellar magnetic stimulation decreases levodopa-induced dyskinesias in Parkinson disease.Q45930045
Asymmetric corticomotor excitability correlations in early Parkinson's disease.Q45978837
Effect of daily repetitive transcranial magnetic stimulation on motor performance in Parkinson's diseaseQ46154284
???Q64819727
???Q64865148
Motor cortex reorganisation in Parkinson's diseaseQ48482152
Effects of antidepressant treatment with rTMS and fluoxetine on brain perfusion in PD.Q48499127
Effect of high frequency repetitive transcranial magnetic stimulation on reaction time, clinical features and cognitive functions in patients with Parkinson's diseaseQ48530348
MEP latency shift after implantation of deep brain stimulation systems in the subthalamic nucleus in patients with advanced Parkinson's diseaseQ48538061
Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open studyQ48552742
Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: implications for the pathophysiology of cortical function.Q48552791
Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinson's diseaseQ48579468
Mechanisms underlying mirror movements in Parkinson's disease: a transcranial magnetic stimulation studyQ48612188
Sensory and motor evoked potentials in multiple system atrophy: a comparative study with Parkinson's diseaseQ48717584
Impaired presynaptic inhibition in the motor cortex in Parkinson diseaseQ48718629
Placebo-controlled study of rTMS for the treatment of Parkinson's diseaseQ48739103
Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's diseaseQ48772949
Reduced cerebellar inhibition in schizophrenia: a preliminary studyQ48874430
Impairment of motor cortex activation and deactivation in Parkinson's diseaseQ48936069
Repetitive transcranial magnetic stimulation to SMA worsens complex movements in Parkinson's diseaseQ49051370
The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson's disease: a randomized, double-blind, placebo-controlled studyQ49069685
Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulationQ49151608
Effects of rTMS on Parkinson's disease: a longitudinal fMRI studyQ50265803
Disturbed surround inhibition in preclinical parkinsonism.Q50276695
MEG evaluation of Parkinson's diseased patients after external magnetic stimulationQ50276774
rTMS treatment for depression in Parkinson's disease increases BOLD responses in the left prefrontal cortex.Q50890848
Efficacy of rTMS in the treatment of co-morbid anxiety in depressed patients with Parkinson's disease.Q50897088
Therapeutic and "dose-dependent" effect of repetitive microelectroshock induced by transcranial magnetic stimulation in Parkinson's disease.Q52032336
Effects of magnetic stimulation over supplementary motor area on movement in Parkinson's disease.Q52519897
Increased corticomotoneuronal excitability after peripheral nerve stimulation in dopa-nonresponsive hemiparkinsonism.Q54179028
Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation studyQ57009926
Hemiparkinson-hemiatrophy syndrome: a transcranial magnetic stimulation studyQ57579239
Plasticity of the motor cortex in Parkinson's disease patientson andoff therapyQ58483121
Long-term follow-up study with repetitive transcranial magnetic stimulation (rTMS) in Parkinson's diseaseQ58852523
Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effectsQ60733379
High-frequency rTMS over the supplementary motor area for treatment of Parkinson's diseaseQ63952437
Short-term motor improvement after sub-threshold 5-Hz repetitive transcranial magnetic stimulation of the primary motor hand area in Parkinson's diseaseQ64767943
Repetitive transcranial magnetic stimulation causes a short-term increase in the duration of the cortical silent period in patients with Parkinson's diseaseQ64786041
Study of central motor functions using magnetic stimulation in Parkinson's diseaseQ64863641
Effects of low-frequency repetitive transcranial magnetic stimulation in Parkinson's diseaseQ64874109
Effects of subthalamic nucleus stimulation on motor cortex excitability in Parkinson's diseaseQ64958496
The relation between bradykinesia and excitability of the motor cortex assessed using transcranial magnetic stimulation in normal and parkinsonian subjectsQ71864765
Resetting of essential tremor and postural tremor in Parkinson's disease with transcranial magnetic stimulationQ72006086
Pulsed magnetic stimulation and F waves in Parkinson's diseaseQ72032595
Abnormal facilitation of the response to transcranial magnetic stimulation in patients with Parkinson's diseaseQ72379366
Changes in excitability of motor cortical circuitry in patients with Parkinson's diseaseQ72525704
Therapeutic effect of repetitive transcranial magnetic stimulation on motor function in Parkinson's disease patientsQ73860876
Treatment with AC pulsed electromagnetic fields normalizes the latency of the visual evoked response in a multiple sclerosis patient with optic atrophyQ74695968
Repetitive transcranial magnetic stimulation of the dominant hemisphere can disrupt visual naming in temporal lobe epilepsy patientsQ77787331
Abnormal responses to repetitive transcranial magnetic stimulation in multiple system atrophyQ79390748
Assessment of cortico-spinal tract impairment in multiple system atrophy using transcranial magnetic stimulationQ79817288
Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's diseaseQ80822356
High-frequency rTMS improves time perception in Parkinson diseaseQ81208795
Pathways mediating abnormal intracortical inhibition in Parkinson's diseaseQ81247582
P433issue6
P407language of work or nameEnglishQ1860
P921main subjectParkinson's diseaseQ11085
P1104number of pages13
P304page(s)573-585
P577publication date2013-03-07
P1433published inParkinsonism and Related DisordersQ15762600
P1476titleSafety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature
P478volume19

Reverse relations

cites work (P2860)
Q92535192Commentary: Activation of Cortical Somatostatin Interneurons Rescues Synapse Loss and Motor Deficits After Acute MPTP Infusion
Q60308782Effect of Low Frequency Repetitive Transcranial Magnetic Stimulation on Depression and Cognition of Patients with Traumatic Brain Injury: A Randomized Controlled Trial
Q38947418Freezing of gait in Parkinson's disease: from pathophysiology to emerging therapies.
Q47798542High-Frequency Continuous Pulsed Magnetic Stimulation Does Not Adversely Affect Development on Whole Body Organs in Female Sprague-Dawley Rats
Q26782971Mechanisms and therapeutic applications of electromagnetic therapy in Parkinson's disease
Q40626246Recognition and treatment of neuropsychiatric disturbances in Parkinson's disease
Q33604756Rehabilitation Treatment and Progress of Traumatic Brain Injury Dysfunction
Q47792299Response to Letter to the Editor regarding "Transcranial magnetic stimulation for treatment-resistant depression: Naturalistic outcomes for younger versus older patients".
Q38953059Safety of Transcranial Magnetic Stimulation in Children: A Systematic Review of the Literature
Q38925121Therapies for Parkinson's diseases: alternatives to current pharmacological interventions.
Q38464043Transcranial magnetic stimulation: A potential new treatment for depression associated with traumatic brain injury

Search more.